The potential role of vaccines in the elimination of falciparum malaria and the eventual eradication of malaria

Journal of Infectious Diseases

Volumn 200, Issue 11, 2009, Pages 1646-1649

  Plowe, Christopher V ^a   Alonso, Pedro ^c,d   Hoffman, Stephen L ^b  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

^b SANARIA INC   (United States)

^c CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^d Manhiça Health Research Center   (Mozambique)

Author keywords

[No Author keywords available]

Indexed keywords

MALARIA VACCINE;

CLINICAL TRIAL; HUMAN; INFECTION PREVENTION; INFECTION RISK; LIFE CYCLE; MALARIA CONTROL; MALARIA FALCIPARUM; NONHUMAN; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SHORT SURVEY; VECTOR CONTROL;

BIOMEDICAL RESEARCH; HUMANS; MALARIA VACCINES; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM;

EID: 72849137064     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/646613     Document Type: Short Survey

References (10)

1. Roberts L, Enserink M. Malaria. Did they really sayeradication? Science 2007; 318:1544-1545
2. Smith DL, McKenzie FE, Snow RW, Hay SI. Revisiting the basic reproductive number for malaria and its implications for malaria control. PLoS Biol 2007; 5:e42.
3. Hoffman SL, Goh LM, Luke TC, et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoite. J Infect Dis 2002; 185:1155-1164
4. Luke TC, Hoffman SL. Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine. J Exp Biol 2003; 206:3803-3808
5. Hoffman SL, Billingsley PF, James E, et al. Development of a metabolically active, nonreplicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Human Vaccines (in press).
6. Wu Y, Ellis RD, Shaffer D, et al. Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51. PLoS One 2008; 3:e2636.
7. United Arab Emirates certified malaria-free. Wkly Epidemiol Rec 2007; 82:30-32
8. Okiro EA, Hay SI, Gikandi PW, et al. The decline in paediatric malaria admissions on the coast of Kenya. Malar J 2007; 6:151.
9. Molineaux L, Gramiccia G. The Garki Project. research on the epidemiology and control of malaria in the Sudan savanna of West Africa. Geneva: World Health Organization, 1980.
10. Garfield RM, Vermund SH. Changes in malaria incidence after mass drug administration in Nicaragua. Lancet 1983; 2:500-503